COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 77 filers reported holding COMPASS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,574,532 | -38.1% | 2,829,712 | 0.0% | 2.21% | -19.1% |
| Q2 2023 | $8,998,484 | -2.8% | 2,829,712 | 0.0% | 2.73% | +11.2% |
| Q1 2023 | $9,253,158 | -35.0% | 2,829,712 | 0.0% | 2.46% | -35.2% |
| Q4 2022 | $14,233,452 | +120.6% | 2,829,712 | 0.0% | 3.79% | +118.5% |
| Q3 2022 | $6,452,000 | -14.0% | 2,829,712 | 0.0% | 1.74% | -39.4% |
| Q2 2022 | $7,499,000 | +93.4% | 2,829,712 | 0.0% | 2.86% | +73.7% |
| Q1 2022 | $3,877,000 | -59.6% | 2,829,712 | -6.4% | 1.65% | -48.2% |
| Q4 2021 | $9,585,000 | – | 3,023,692 | – | 3.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,500,000 | $11,165,000 | 7.28% |
| Foresite Capital Management V, LLC | 4,400,000 | $13,948,000 | 3.43% |
| CHI Advisors LLC | 3,023,692 | $9,585,000 | 3.18% |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $3,487,000 | 2.34% |
| Monashee Investment Management LLC | 2,000,000 | $6,340,000 | 1.57% |
| Orbimed Advisors | 21,642,975 | $68,608,000 | 0.88% |
| Rock Springs Capital Management LP | 5,328,088 | $16,890,000 | 0.39% |
| Vivo Capital, LLC | 2,000,000 | $6,340,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,000 | $2,219,000 | 0.24% |
| DAFNA Capital Management LLC | 196,091 | $622,000 | 0.16% |